Impact of Losartan on Stroke Risk in Hypertensive Patients in Primary Care

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.27, Iss.5, 2007-01, pp. : 347-355

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Losartan: In the Reduction of Stroke Risk in Patients with Hypertension and Left Ventricular Hypertrophy

By Waugh J. Keating G.M.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 5, 2003-01 ,pp. : 371-377

Adis International

Access to resources Recommend Favorite

Implementation of a Pharmacist-Led Clinic for Hypertensive Patients in Primary Care – A Pilot Study

By Reid Fiona Murray Pat Storrie Marion

Pharmacy World and Science, Vol. 27, Iss. 3, 2005-06 ,pp. : 202-207

Springer Publishing Company

Access to resources Recommend Favorite

Losartan: A Review of its Use in Stroke Risk Reduction in Patients with Hypertension and Left Ventricular Hypertrophy

By Moen Marit D. Wagstaff Antona J.

Drugs, Vol. 65, Iss. 18, 2005-01 ,pp. : 2657-2674

Adis International

Access to resources Recommend Favorite

Losartan/Hydrochlorothiazide: A Review of its Use in the Treatment of Hypertension and for Stroke Risk Reduction in Patients with Hypertension and Left Ventricular Hypertrophy

By Keating Gillian M.

Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. : 1239-1265

Adis International

Access to resources Recommend Favorite

Losartan, alone or in combination with hydrochlorothiazide, lowers BP in patients who are hypertensive and obese

Inpharma, Vol. 1, Iss. 1635, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite